Dexmedetomidine as an adjuvant to bupivacaine in caudal analgesia in children.
Vigya Goyal, Jyotsna Kubre, Krishnaprabha Radhakrishnan
https://pubmed.ncbi.nlm.nih.gov/27212752Actively Recruiting
Led by Ain Shams University · Updated on 2026-05-07
72
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the impact of adding dexmedetomidine or ketamine to bupivacaine in caudal blocks on pain relief during and after lumbosacral surgeries performed under general anesthesia. This phase 3 randomized controlled trial aims to compare how these combinations affect perioperative pain management. Participants will receive one of three treatments during surgery: plain bupivacaine alone, bupivacaine with dexmedetomidine, or bupivacaine with ketamine, all given via a fluoroscopy-guided caudal block. Standard general anesthesia and monitoring will be applied, with detailed procedures for administering the block under imaging guidance. Postoperative pain will be managed with scheduled IV ketorolac and paracetamol, with morphine available as rescue medication if pain scores are high. Participants will be assessed before surgery with medical history and routine tests, and trained to use a pain scale. During surgery and recovery, vital signs will be closely monitored. Pain intensity will be recorded at several intervals up to 24 hours post-surgery, along with opioid use and side effects like nausea or low blood pressure. The main outcome is the duration of pain relief when pain reaches a set level. Data collection is blinded to treatment allocation to ensure unbiased results.
CONDITIONS
Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral Surgeries
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for clinical assessment and routine preoperative investigations
Duration - Surgery day
Participants receive general anesthesia and a fluoroscopy guided caudal analgesia with either bupivacaine alone or combined with dexmedetomidine or ketamine during lumbosacral surgery.
1 intraoperative visit and monitoring during surgery
Duration - 24 hours post-surgery
Participants are monitored postoperatively for pain severity using the visual analog scale and receive scheduled analgesics. Rescue analgesia is provided as needed. Vital signs and side effects are regularly assessed in the first 24 hours after surgery.
Multiple assessments at 0, 2, 4, 6, 8, 12, 16 and 24 hours postoperatively in PACU and surgical ward
Total: 1 location
1
Ain Shams University hospitals
Cairo, Egypt
Actively Recruiting
S
Salma Ayman Abdulazeem, MSc
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Vigya Goyal, Jyotsna Kubre, Krishnaprabha Radhakrishnan
https://pubmed.ncbi.nlm.nih.gov/27212752Marion Wiegele, Peter Marhofer, Per-Arne Lönnqvist
https://pubmed.ncbi.nlm.nih.gov/30857607Guy Barham, Andrew Hilton
https://pubmed.ncbi.nlm.nih.gov/20512512Serbülent Gökhan Beyaz, Orhan Tokgöz, Adnan Tüfek
https://pubmed.ncbi.nlm.nih.gov/21911987Valeria Mossetti, Noemi Vicchio, Giorgio Ivani
https://pubmed.ncbi.nlm.nih.gov/22512395Sukhminder Jit Singh Bajwa, Sukhwinder Kaur Bajwa, Jasbir Kaur...
https://pubmed.ncbi.nlm.nih.gov/21712865S L Solanki, N Bharti, Y K Batra...
https://pubmed.ncbi.nlm.nih.gov/23362890Thomas R Vetter, Daniel Carvallo, Jodie L Johnson...
https://pubmed.ncbi.nlm.nih.gov/17513626C Sekar, S Rajasekaran, Rajesh Kannan...
https://pubmed.ncbi.nlm.nih.gov/15125846